Compare INVA & QNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INVA | QNT |
|---|---|---|
| Founded | 1996 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | 2000 | 2026 |
| Metric | INVA | QNT |
|---|---|---|
| Price | $20.61 | $46.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 13 |
| Target Price | $35.00 | ★ $97.17 |
| AVG Volume (30 Days) | 733.2K | ★ 1.5M |
| Earning Date | 11-04-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 816.67 | N/A |
| EPS | ★ 1.25 | N/A |
| Revenue | ★ $217,217,000.00 | N/A |
| Revenue This Year | $9.72 | N/A |
| Revenue Next Year | $8.58 | $102.03 |
| P/E Ratio | $16.88 | ★ N/A |
| Revenue Growth | ★ 62.63 | N/A |
| 52 Week Low | $16.52 | $46.54 |
| 52 Week High | $25.15 | $86.79 |
| Indicator | INVA | QNT |
|---|---|---|
| Relative Strength Index (RSI) | 50.35 | 42.53 |
| Support Level | $20.39 | $46.94 |
| Resistance Level | $21.73 | $53.25 |
| Average True Range (ATR) | 0.47 | 2.84 |
| MACD | 0.04 | 0.09 |
| Stochastic Oscillator | 66.39 | 15.27 |
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
Quantinuum Inc. is providing a full-stack quantum technology solution to scale quantum computing and develop applications. Its products and solutions are Quantinuum Systems, Helios, Quantum Origin, InQuanto, Nexus, and Developer Tools.